Table 5 Patient characteristics depending from 6-[18F]FDOPA and N1 results
From: Comparison of 6-[18F]FDOPA PET with Nigrosome 1 detection in patients with parkinsonism
Characteristics | 6-[18F]FDOPA abnormal/N1 abnormal | 6-[18F]FDOPA normal/N1 normal | 6-[18F]FDOPA abnormal/N1 normal | 6-[18F]FDOPA normal/N1 abnormal | p value |
|---|---|---|---|---|---|
No. of male/female patients | 13/9 | 5/8 | 2/2 | 3/1 | 0.553 |
Age (years) mean ± SD (range) | 62.09 ± 11.11 (38–82) | 64.31 ± 15.96 (20–81) | 69.25 ± 6.80 (62–76) | 60.75 ± 9.64 (51–74) | 0.714 |
Duration of disease (years) mean ± SD (range) | 2.50 ± 2.06 (1–10) | 4.38 ± 3.57 (1–10) | 1.50 ± 0.58 (1–2) | 5.25 ± 4.03 (1–10) | 0.070 |
Activity (MBq) mean ± SD | 215.32 ± 16.95 | 218.08 ± 21.08 | 209.75 ± 20.16 | 210.25 ± 19.76 | 0.820 |